
Noggin belongs to a group of diffusible proteins that bind to ligands of the TGF-β family, and regulate their activity by inhibiting their access to signaling receptors. Noggin was originally identified as a BMP-4 antagonist whose action was critical for proper formation of the head and other dorsal structures. Consequently, noggin has been shown to modulate the activities of other BMPs including BMP-2,-7,-13, and -14. Targeted deletion of noggin in mice results in prenatal death, and a recessive phenotype displaying a severely malformed skeletal system. Conversely, transgenic mice over-expressing noggin in mature osteoblasts display impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis. Recombinant Murine Noggin is a 46.4 kDa disulfide-linked homodimer consisting of two 206 amino acid polypeptide chains.

V roku 2007 získali Nobelovu cenu za fyziológiu alebo medicínu Mario R. Capecchi (USA), Sir Martin E...
Čítať viac
Trh s farmaceutickymi a biologickymi liekmi ponuka siroku skalu pripravkov urcenych na liecbu mnohyc...
Čítať viac
S oteplovanim pocasia rastie aj riziko prisatia kliestov. Tieto drobne pavukovce prenasaju mnoho roz...
Čítať viac